@FierceBiotech: Bluebird posts more promising results with its rare disease therapy. Story | Follow @FierceBiotech
@DamianFierce: So the billionaire Russian oligarch who bought Watson's Nobel medal for $4.1 million is giving it back because hey. More | Follow @DamianFierce
> Nanomedicine developer Midatech priced a £32 million ($50 million) London IPO, immediately spending some of its proceeds to acquire Q Chip, a Welsh firm with a proprietary technology for sustained-release formulation. News
> PaxVax's cholera vaccine met its primary endpoint in a Phase III trial, the company said, setting the stage for an FDA application in mid-2015. Story
> Valeant Pharmaceuticals ($VRX), famed for its serial acquisitions, is planning to take a break from dealmaking to focus on its mounting debt, according to Reuters. Article
Medical Device News
@FierceMedDev: ICYMI yesterday: Edwards gains option to acquire startup CardioKinetix in $50M financing. Article | Follow @FierceMedDev
@EmilyWFierce: Stryker's OtisMed to pay more than $80M to settle DOJ case over knee replacement surgical devices. Story | Follow @EmilyWFierce
> Eurofins Scientific snaps up Boston Heart Diagnostics for $140M. Story
> Brain sensors go wireless in Brown University study. More
> Edwards looks to TAVR to convince Wall Street it can go higher after doubling in 2014. Article
Pharma News
@FiercePharma: Did Merck pay $3B too much for Cubist? Analysts weigh impact of Cubicin patent loss. Story | Follow @FiercePharma
@CarlyHFierce: AbbVie's Humira competition begins with Cadila's biosimilar launch in India. More | Follow @CarlyHFierce
> Long-term painkiller use on the rise, with more patients taking dangerous combos. Story
> J&J discount offer wins NICE over to new use for Stelara. Article
> Valeant temporarily swears off dealmaking to cut debt--and prove it's not desperate. News
Biotech Research News
> Epizyme showcases a successful preclinical lymphoma program for third target. More
> MicroRNA holds clues to predicting progression-free myeloma survival. Report
> New malaria drug unleashes an immune system assault on infected cells. Story
> Could alpha secretase offer a better approach to fighting Alzheimer's? More
> PKCƐ pathway offers a new line of attack against cancer cells. Article
Pharma Manufacturing News
> India's Zydus Cadila finds blood pressure med has embedded brown spots. Story
> Ferring preps for first U.S. plant opening as it moves to New Jersey campus. More
> FDA notches a win after Tennessee compounder pleads guilty. Report
> Meda drops Recipharm contract; plant may be forced to close. Story
> Daewoong inks deal to build $188M facility in South Korea. Article